PharmD Degree Program
سان فرانسيسكو , الولايات المتحدة
زيارة موقع البرنامج
مصاريف
غير متاح
تاريخ البدء
غير متاح
وسيلة الدراسة
غير متاح
مدة
غير متاح
حقائق البرنامج
تفاصيل البرنامج
درجة
درجة الدكتوراه
تخصص رئيسي
علوم الغذاء | العلوم العامة | علم الوراثة
التخصص
الطب والصحة
لغة الدورة
إنجليزي
عن البرنامج
نظرة عامة على البرنامج
University of California San Francisco PharmD Degree Program
Program Overview
The University of California San Francisco (UCSF) offers a PharmD Degree Program designed to educate and train students in the field of pharmacy. The program is structured to provide students with a comprehensive education in pharmacy practice, pharmaceutical sciences, and clinical pharmacy.
Admissions
- Admissions Overview: The program accepts applications from students who have completed the required pre-pharmacy coursework.
- Policies and Disclosures: The program adheres to the policies and disclosures set forth by the University of California San Francisco.
- Financial Aid and Cost: Financial aid and cost information is available to prospective students.
- Application Process: The application process involves submitting an application, transcripts, and letters of recommendation.
- Frequently Asked Questions and Tips: The program provides answers to frequently asked questions and tips for applicants.
- Applying Without U.S. Citizenship or Permanent Resident Status: International students may apply to the program.
- PharmD-PhD: The program offers a combined PharmD-PhD degree option.
- Post-Baccalaureate Program: A post-baccalaureate program is available for students who have completed a bachelor's degree.
- Pharm Tech to PharmD Pathway Program: A pathway program is available for pharmacy technicians.
Student Life
- Student Life Overview: The program provides students with a supportive and inclusive learning environment.
- Year 1 Perspective: First-year students can expect to engage in foundational coursework and clinical experiences.
- Year 2 Perspective: Second-year students can expect to build on their foundational knowledge and develop clinical skills.
- Year 3 Perspective: Third-year students can expect to engage in advanced clinical experiences and prepare for graduation.
- Past Student Perspectives Overview: The program provides opportunities for students to share their experiences and perspectives.
Curriculum
- Curriculum Overview: The program's curriculum is designed to provide students with a comprehensive education in pharmacy practice, pharmaceutical sciences, and clinical pharmacy.
- Program Timeline: The program is typically completed in four years.
- Component 1 - Foundations: The first component of the curriculum focuses on foundational knowledge in pharmacy practice and pharmaceutical sciences.
- Component 2 - Integrated Themes: The second component of the curriculum integrates foundational knowledge with clinical practice.
- Component 3 - Patient Care Skills: The third component of the curriculum focuses on developing patient care skills.
- Component 4 - Practice Rotations: The fourth component of the curriculum provides students with clinical experience through practice rotations.
- Component 5 - Discovery Project: The fifth component of the curriculum involves a discovery project that allows students to explore a topic of interest.
- Progress and Feedback: The program provides regular progress assessments and feedback to students.
- Curriculum Outcomes: The program's curriculum is designed to achieve specific outcomes, including the development of clinical skills and knowledge.
Graduation Rate and Graduate Performance
- Graduation Rate: The program's graduation rate is as follows:
- 2025: 88% graduated in 3 years, TBD graduated in > 3 years
- 2024: 90% graduated in 3 years, 5% graduated in > 3 years
- 2023: 92% graduated in 3 years, 5% graduated in > 3 years
- 2022: 91% graduated in 3 years, 7% graduated in > 3 years
- 2021 (transformed 3-year curriculum): 96% graduated in 3 years, n/a graduated in > 3 years
- 2021 (4-year curriculum): 99% graduated in 4 years, n/a graduated in > 4 years
- 2020: 95% graduated in 4 years, 3% graduated in > 4 years
- 2019: 95% graduated in 4 years, 3% graduated in > 4 years
- 2018: 94% graduated in 4 years, 3% graduated in > 4 years
- 2017: 90% graduated in 4 years, 3% graduated in > 4 years
- 2016: 93% graduated in 4 years, 7% graduated in > 4 years
- 2015: 97% graduated in 4 years, 2% graduated in > 4 years
- 2014: 95% graduated in 4 years, 4% graduated in > 4 years
- 2013: 94% graduated in 4 years, 5% graduated in > 4 years
- 2012: 94% graduated in 4 years, 5% graduated in > 4 years
- 2011: 99% graduated in 4 years, 1% graduated in > 4 years
- 2010: 93% graduated in 4 years, 3% graduated in > 4 years
- 2009: 97% graduated in 4 years, 2% graduated in > 4 years
- Post-graduate plans: The program's graduates have pursued various post-graduate plans, including:
- Residency: 58% (2025), 66% (2024), 73% (2023), 73% (2022), 61% (2021 transformed), 68% (2021 legacy), 69% (2020), 61% (2019), 63% (2018), 67% (2017), 59% (2016), 61% (2015), 50% (2014), 54% (2013), 60% (2012), 64% (2011), 59% (2010)
- Pharmacy job: 1% (2025), 3% (2024), 4% (2023), 9% (2022), 10% (2021 transformed), 6% (2021 legacy), 11% (2020), 13% (2019), 14% (2018), 17% (2017), 25% (2016), 20% (2015), 33% (2014), 32% (2013), 25% (2012), 19% (2011), 30% (2010)
- Fellowship: 7% (2025), 7% (2024), 5% (2023), 9% (2022), 3% (2021 transformed), 11% (2021 legacy), 6% (2020), 9% (2019), 7% (2018), 5% (2017), 3% (2016), 4% (2015), 7% (2014), 2% (2013), 5% (2012), 2% (2011), 5% (2010)
- Non-pharmacy job: 1% (2025), 1% (2024), 1% (2023), 3% (2022), 1% (2021 transformed), 4% (2021 legacy), 0% (2020), 0% (2019), 0% (2018), 0% (2017), 0% (2016), 1% (2015), 2% (2014), 0% (2013), 1% (2012), 1% (2011), 0% (2010)
- Another degree: 2% (2025), 0% (2024), 0% (2023), 2% (2022), 0% (2021 transformed), 1% (2021 legacy), 0% (2020), 1% (2019), 1% (2018), 1% (2017), 2% (2016), 0% (2015), 2% (2014), 2% (2013), 1% (2012), 1% (2011), 1% (2010)
- Other: 0% (2025), 2% (2024), 0% (2023), 2% (2022), 9% (2021 transformed), 3% (2021 legacy), 3% (2020), 6% (2019), 5% (2018), 5% (2017), 3% (2016), 5% (2015), 3% (2014), 4% (2013), 2% (2012), 1% (2011), 3% (2010)
- To be determined: 31% (2025), 22% (2024), 17% (2023), 2% (2022), 15% (2021 transformed), 8% (2021 legacy), 11% (2020), 10% (2019), 10% (2018), 5% (2017), 7% (2016), 9% (2015), 3% (2014), 6% (2013), 6% (2012), 12% (2011), 3% (2010)
- American Society of Health-System Pharmacists (ASHP) PGY1 residency match:
- 2025: 90 participated, 72 matched, 80% match rate
- 2024: 93 participated, 80 matched, 86% match rate
- 2023: 99 participated, 84 matched, 85% match rate
- 2022: 102 participated, 89 matched, 87% match rate
- 2021: 173 participated, 131 matched, 76% match rate
- NAPLEX results for first-time takers:
- 2024: 89.70% (UCSF), 77.50% (national)
- 2023: 83.30% (UCSF), 76.60% (national)
- 2022: 91.10% (UCSF), 77.40% (national)
- 2021: 90.00% (UCSF), 81.00% (national)
- 2020: 98.00% (UCSF), 86.00% (national)
- 2019: 96.15% (UCSF), 88.34% (national)
- 2018: 91.15% (UCSF), 89.46% (national)
- 2017: 98.13% (UCSF), 87.95% (national)
- 2016: 96.40% (UCSF), 85.86% (national)
- 2015: 99.15% (UCSF), 92.64% (national)
- 2014: 99.13% (UCSF), 94.88% (national)
- 2013: 98.08% (UCSF), 95.87% (national)
عرض المزيد
